Atlas Trials

Hemophilia B with Inhibitor

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hemophilia B with Inhibitor

RecordFirmDate
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors (NCT04647227)American Thrombosis and Hemostasis Network2021-06-28
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B (NCT04489537)Catalyst Biosciences2021-05-04
Study on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With Inhibitors (NCT04789954)AryoGen Pharmed Co.2020-12-29
Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia. (NCT04768699)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2020-12-01
Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia (NCT04072237)Catalyst Biosciences2019-09-24
ATHN 7: Hemophilia Natural History Study (NCT03619863)American Thrombosis and Hemostasis Network2018-10-24
ATHN 8: Previously Untreated Patients (PUPs) Matter Study (NCT03818529)American Thrombosis and Hemostasis Network2018-10-03
Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B (NCT03407651)Catalyst Biosciences2017-12-18
Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven (NCT03372993)AryoGen Pharmed Co.2016-06-13

Track Hemophilia B with Inhibitor automatically

Every clearance here is in the API, with alerts when new ones post.